Literature DB >> 9397023

Granulocyte-macrophage colony-stimulating factor crosses the blood--brain and blood--spinal cord barriers.

R N McLay1, M Kimura, W A Banks, A J Kastin.   

Abstract

Granulocyte-macrophage colony-stimulating factor (GM-CSF), a glycoprotein with hormonal properties, is produced by several cell types, most of which exist outside the CNS. GM-CSF, however, affects the CNS. If capable of crossing from blood to CNS, GM-CSF might be an important signalling molecule between the CNS and periphery. We used an established in vivo method in mice and rats to study passage of radioactively labelled GM-CSF from blood to CNS. We found that GM-CSF crossed the blood-brain barrier and blood-spinal cord barrier significantly faster than the control substance, albumin. Labelled GM-CSF was recovered in intact form by high performance liquid chromatography from brain after peripheral injection, and passage was not significantly reduced by simultaneous injection of unlabelled L-tryptophan. Both findings indicate that the observed passage of radioactivity was intact protein. Capillary depletion experiments showed that most of the GM-CSF was deposited in brain parenchyma rather than cerebral capillary endothelium. Co-injection of unlabelled GM-CSF significantly reduced the passage rate of labelled cytokine across the blood-brain and blood-spinal cord barriers, demonstrating that passage was mediated by a saturable system. In summary, a saturable mechanism transports GM-CSF intact from blood to CNS.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9397023     DOI: 10.1093/brain/120.11.2083

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  32 in total

1.  GM-CSF upregulated in rheumatoid arthritis reverses cognitive impairment and amyloidosis in Alzheimer mice.

Authors:  Tim D Boyd; Steven P Bennett; Takashi Mori; Nicholas Governatori; Melissa Runfeldt; Michelle Norden; Jaya Padmanabhan; Peter Neame; Inge Wefes; Juan Sanchez-Ramos; Gary W Arendash; Huntington Potter
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 2.  Concepts for biologically active peptides.

Authors:  Abba J Kastin; Weihong Pan
Journal:  Curr Pharm Des       Date:  2010-10       Impact factor: 3.116

3.  pH responsive granulocyte colony-stimulating factor variants with implications for treating Alzheimer's disease and other central nervous system disorders.

Authors:  Pete Heinzelman; Jennifer A Schoborg; Michael C Jewett
Journal:  Protein Eng Des Sel       Date:  2015-04-15       Impact factor: 1.650

4.  GM-CSF action in the CNS decreases food intake and body weight.

Authors:  Jacquelyn A Reed; Deborah J Clegg; Kathleen Blake Smith; Emeline G Tolod-Richer; Emily K Matter; Lara S Picard; Randy J Seeley
Journal:  J Clin Invest       Date:  2005-11       Impact factor: 14.808

Review 5.  Blood-brain barrier and feeding: regulatory roles of saturable transport systems for ingestive peptides.

Authors:  Abba J Kastin; Weihong Pan
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

6.  Anti-cytokine autoantibodies in autoimmune diseases.

Authors:  Giuseppe Cappellano; Elisabetta Orilieri; Abiy D Woldetsadik; Elena Boggio; Maria F Soluri; Cristoforo Comi; Daniele Sblattero; Annalisa Chiocchetti; Umberto Dianzani
Journal:  Am J Clin Exp Immunol       Date:  2012-11-15

7.  Granulocyte-macrophage colony-stimulating factor antibody suppresses microglial activity: implications for anti-inflammatory effects in Alzheimer's disease and multiple sclerosis.

Authors:  P Hemachandra Reddy; Maria Manczak; Wei Zhao; Kazuhiro Nakamura; Christopher Bebbington; Geoffrey Yarranton; Peizhong Mao
Journal:  J Neurochem       Date:  2009-10-14       Impact factor: 5.372

8.  GM-CSF induces neuroprotective and anti-inflammatory responses in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxicated mice.

Authors:  Lisa M Kosloski; Elizabeth A Kosmacek; Katherine E Olson; R Lee Mosley; Howard E Gendelman
Journal:  J Neuroimmunol       Date:  2013-10-29       Impact factor: 3.478

9.  ZO-1 expression is suppressed by GM-CSF via miR-96/ERG in brain microvascular endothelial cells.

Authors:  Hu Zhang; Shuhong Zhang; Jilin Zhang; Dongxin Liu; Jiayi Wei; Wengang Fang; Weidong Zhao; Yuhua Chen; Deshu Shang
Journal:  J Cereb Blood Flow Metab       Date:  2017-04-21       Impact factor: 6.200

10.  Granulocyte Macrophage Colony Stimulating Factor Treatment is Associated with Improved Cognition in Cancer Patients.

Authors:  Heather Sl Jim; Tim D Boyd; Margaret Booth-Jones; Joseph Pidala; Huntington Potter
Journal:  Brain Disord Ther       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.